Last reviewed · How we verify
NCT03633240: ER2
Emergency Room Visits and Older Patients (ER2)
trial testing ER assessment in Emergencies in 356 participants. Completed in 1 July 2024.
1 September 2021
Quick facts
| Lead sponsor | Jewish General Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 356 |
| Start date | 1 September 2017 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- ER assessment
Conditions studied
- Emergencies — all drugs for Emergencies →
- Length of Stay — all drugs for Length of Stay →
Sponsor
Jewish General Hospital
Who can join
65 and older, any sex, with Emergencies or Length of Stay. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Today's population is living longer than prior generations. Senior patients, defined as 65 years or older, are therefore increasing in number, and representing a larger number of hospitalized patients. Thus, assessing and addressing the needs of the growing number of older ER users is essential. The overall objective of the study is to examine the feasibility and the epidemiology of two screening tools ("Programme de Recherche sur l'Intégration des Services pour le Maintien de l'Autonomie" (PRISMA-7) and Emergency Room Evaluation and recommendations (ER2)) used in the Emergency Room of Jewish General Hospital to screen older patients (i.e.; ≥65 years) at risk of adverse health events. A prospective observational cohort design will be used for the study's two phases; phase 1- assessment and phase 2- assessment as well as recommendations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03633240
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emergencies
Currently open trials in the same condition.
- NCT06565390 — Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization · NA · recruiting
- NCT07051668 — The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls · NA · recruiting
- NCT06680778 — Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch · recruiting
- NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
Other Jewish General Hospital trials
Trials by the same sponsor.
- NCT05188222 — Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery · Phase 4 · not yet recruiting
- NCT06701929 — The Impact of Fasting Duration on Quality of Recovery After Cesarean Section · recruiting
- NCT05719415 — Functional Pulmonary Capillary Surface Area in BPA for CTEPH · NA · recruiting
- NCT04678986 — ER2 and Deep Learning for Prediction of Adverse Health Outcomes · withdrawn
- NCT04893876 — The OPERa Study: Evaluating QoL After Rectal Cancer Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03633240 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jewish General Hospital
- Last refreshed: 23 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03633240.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing